Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 26 symbols : Sny save search
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published: 2021-10-26 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: 0.39%
H: 0.23%
C: -1.13%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.4%
H: 1.16%
C: -5.35%
covid fda children vaccine merge emergency use authorization
Benuvia Manufacturing Appoints Scott Aladeen as Chief Operating Officer
Published: 2021-10-26 (Crawled : 15:15) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer
Published: 2021-10-26 (Crawled : 14:15) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
pharma
Amylyx Pharmaceuticals Hires Stéphanie Hoffmann-Gendebien, MBA, as Head, General Manager EMEA
Published: 2021-10-26 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Published: 2021-10-26 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
UNCY | $1.07 120K
|
Professional, Scientific, and T...
|
| O: 7.11%
H: 5.17%
C: 1.85%
ABT | News | $106.96 -0.59% 2.6M
|
Health Technology
|
| O: 0.2%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
Provention Bio Announces Positive Interim Results from First-In-Human Study of Coxsackievirus B Vaccine Candidate PRV-101
Published: 2021-10-26 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
positive results vaccine coxsackievirus prv-101
Tal Zaks Joins Strategic Advisory Board at Deep Genomics
Published: 2021-10-26 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
genomic
Innate Pharma 2022 Financial Calendar
Published: 2021-10-26 (Crawled : 10:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 4.1%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
NVO | News | $126.09 -1.98% 2.2M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
IPHA | $2.37 170
|
Health Technology
|
| O: 4.17%
H: 3.45%
C: 2.91%
pharma
Evotec Provides Preliminary Nine Month Financial Results
Published: 2021-10-26 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
financial results results
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
RBBN 4 | $3.29 28.02% 2.2M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.